Literature DB >> 31632571

An experimental research into the potential therapeutic effects of Anti-Osteoporosis Decoction and Yougui Pill on ovariectomy-induced osteoporosis.

Fulong Gu1, Jiang Jiang1, Sheng Wang1, Tao Feng1, Yi Zhou1, Yong Ma2, Shuijie Shen3.   

Abstract

Many traditional Chinese medicine tonifying prescriptions for kidney and spleen have been proved to play various roles in osteoporosis. This study aimed to explore whether Anti-Osteoporosis Decoction (AOD) and Yougui Pill (YGP) have potential therapeutic effects on osteoporosis in ovariectomy-induced rat model. The osteoporosis rat model was established with female Wistar rats by the way of ovariectomy. The chosen rats were randomly divided into five groups (control group, model group, sham group, model + AOD group, and model + YGP group). H&E staining was used to detect the bone histological pathology changes. The bone mineral density (BMD) was assessed with dual-energy X-ray absorptiometry. In addition, western blotting assay was applied to explore the expressions of BMP2, Runx2, Collagen I and Opn. Next, we examined the expression of collagen I by immunohistochemistry staining. Finally, the levels of Alkaline phosphatase (ALP), procollagen type I N propeptide (PINP) and β-C-terminal telopeptide of type I collagen (β-CTX) were detected. The results revealed that the OVX osteoporosis model was successfully established. AOD and YGP treatment effectively inhibited osteoporosis and reduced the broken trabecular bones. BMD was increased in AOD and YGP treatment. In addition, AOD and YGP treatment groups significantly increased the ALP levels. Furthermore, AOD and YGP significantly increased the expressions of BMP2, Runx2, Collagen I and Opn, while reduced the levels of PINP and β-CTX in serum compared to OVX model group. In conclusion, AOD and YGP exert regulatory effects on osteoporosis in ovariectomized rats. They may be potential candidates for the therapy and cure of human osteoporosis. AJTR
Copyright © 2019.

Entities:  

Keywords:  Anti-Osteoporosis Decoction; BMD; Yougui Pill; bone metabolism; osteoporosis; ovariectomy

Year:  2019        PMID: 31632571      PMCID: PMC6789260     

Source DB:  PubMed          Journal:  Am J Transl Res            Impact factor:   4.060


  35 in total

Review 1.  Use of CTX-I and PINP as bone turnover markers: National Bone Health Alliance recommendations to standardize sample handling and patient preparation to reduce pre-analytical variability.

Authors:  P Szulc; K Naylor; N R Hoyle; R Eastell; E T Leary
Journal:  Osteoporos Int       Date:  2017-06-19       Impact factor: 4.507

Review 2.  Involutional osteoporosis.

Authors:  B L Riggs; L J Melton
Journal:  N Engl J Med       Date:  1986-06-26       Impact factor: 91.245

3.  [Polymorphism of bone morphogenetic protein (BMP2) and osteoporosis etiology].

Authors:  Hubert Wolski; Anna Bogacz; Joanna Bartkowiak-Wieczorek; Agnieszka Greber; Wojciech Pieńkowski; Krzysztof Drews; Andrzej Klejewski; Agnieszka Seremak-Mrozikiewicz
Journal:  Ginekol Pol       Date:  2015-03       Impact factor: 1.232

4.  Osteoprotective effect of geraniin against ovariectomy-induced bone loss in rats.

Authors:  Yiqin Lu; Bo He; Xiaochao Zhang; Renhua Yang; Shude Li; Bo Song; Yue Zhang; Yu Yun; Hongli Yan; Peng Chen; Zhiqiang Shen
Journal:  Bioorg Med Chem Lett       Date:  2014-12-05       Impact factor: 2.823

5.  The serum level of bone-specific alkaline phosphatase activity is associated with aortic calcification in osteoporosis patients.

Authors:  Kousuke Iba; Junichi Takada; Toshihiko Yamashita
Journal:  J Bone Miner Metab       Date:  2004       Impact factor: 2.626

6.  Evaluation of Correlation between Salivary Calcium, Alkaline Phosphatase and Osteoporosis- A Prospective, Comparative and Observational Study.

Authors:  Mainak Kanti Saha; Prerna Agrawal; Suparna Ganguly Saha; Vinod Vishwanathan; Vandana Pathak; Sakuru Venkata Saiprasad; Purvi Dhariwal; Mahendra Dave
Journal:  J Clin Diagn Res       Date:  2017-03-01

Review 7.  Markers of bone turnover for the prediction of fracture risk and monitoring of osteoporosis treatment: a need for international reference standards.

Authors:  S Vasikaran; R Eastell; O Bruyère; A J Foldes; P Garnero; A Griesmacher; M McClung; H A Morris; S Silverman; T Trenti; D A Wahl; C Cooper; J A Kanis
Journal:  Osteoporos Int       Date:  2010-12-24       Impact factor: 4.507

Review 8.  Recent advances in the pathogenesis and treatment of osteoporosis.

Authors:  Elizabeth M Curtis; Rebecca J Moon; Elaine M Dennison; Nicholas C Harvey; Cyrus Cooper
Journal:  Clin Med (Lond)       Date:  2016-08       Impact factor: 2.659

9.  Chinese herbal medicine for osteoporosis: a systematic review of randomized controlled trails.

Authors:  Zhi-Qian Wang; Jin-Long Li; Yue-Li Sun; Min Yao; Jie Gao; Zhu Yang; Qi Shi; Xue-Jun Cui; Yong-Jun Wang
Journal:  Evid Based Complement Alternat Med       Date:  2013-01-30       Impact factor: 2.629

Review 10.  PINP as a biological response marker during teriparatide treatment for osteoporosis.

Authors:  J H Krege; N E Lane; J M Harris; P D Miller
Journal:  Osteoporos Int       Date:  2014-03-06       Impact factor: 4.507

View more
  4 in total

1.  Deciphering the Underlying Mechanism of Eucommiae Cortex against Osteoporotic Fracture by Network Pharmacology.

Authors:  Yongming Shuai; Zhili Jiang; Qiuwen Yuan; Shuqiang Tu; Fanhui Zeng
Journal:  Evid Based Complement Alternat Med       Date:  2020-09-07       Impact factor: 2.629

2.  Deciphering the underlying mechanism of Xianlinggubao capsule against osteoporosis by network pharmacology.

Authors:  Hangsheng Bao; Huizhi Guo; Zongquan Feng; Xin Li
Journal:  BMC Complement Med Ther       Date:  2020-07-03

3.  In Silico Network Analysis of Ingredients of Cornus officinalis in Osteoporosis.

Authors:  Feiqi Huang; Huizhi Guo; Yuanbiao Wei; Xiao Zhao; Yangsheng Chen; Zhan Lin; Yanhui Zhou; Ping Sun
Journal:  Med Sci Monit       Date:  2021-04-02

Review 4.  Biological Deciphering of the "Kidney Governing Bones" Theory in Traditional Chinese Medicine.

Authors:  Hanmin Zhu; Qi Liu; Wei Li; Shuming Huang; Bo Zhang; Yumei Wang
Journal:  Evid Based Complement Alternat Med       Date:  2022-03-29       Impact factor: 2.629

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.